Have you been diagnosed with Adrenal tumour? Here are the top 10 signs that will help you know if its cancerous or not!

The FDA has approved Neurocrine Bioscience's Crenessity for classic congenital adrenal hyperplasia (CAH), the first drug for ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Neurocrine Biosciences, Inc. for the ...

"Today's approval provides an important advance for patients with classic congenital adrenal hyperplasia and highlights the FDA's continued commitment to advancing effective and safe treatments ...

This prevents the adrenal glands from producing enough cortisol ... for classic CAH in 70 years and offers a groundbreaking approach for treatment, according to Neurocrine Biosciences, the drug ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...

particularly if the adrenal tissue is inadvertently damaged during resection (25). This case emphasizes the importance of a multidisciplinary approach for the evaluation and management of pediatric ...

Neurocrine’s Crenessity approval for CAH treatment represents a transformative opportunity. See why I maintain my strong buy ...